Study guide

10.1 Cellular Adaptation and Mechanisms of Cell Death

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

10.1 Cellular Adaptation and Mechanisms of Cell Death

Key Takeaways Explain This Topic AI

Masseteric hypertrophy, drug-induced gingival enlargement, alveolar ridge resorption and necrotising sialometaplasia illustrate hypertrophy, hyperplasia, atrophy and metaplasia respectively.

The three drug classes causing gingival enlargement are anticonvulsants such as phenytoin, calcium channel blockers such as amlodipine and nifedipine, and immunosuppressants such as ciclosporin.

Necrosis is ATP-depleted, causes membrane rupture and provokes intense inflammation; apoptosis is ATP-dependent, caspase-mediated and non-inflammatory.

Pulp necrosis is liquefactive, tuberculous lymphadenitis is caseous, and noma is gangrenous necrosis.

Last updated: September 2026

1. Cellular Adaptations to Environmental Stress

Cells maintain a tightly regulated physiological steady state (homeostasis). Excessive physiological stress or pathological stimuli induce reversible adaptive responses to preserve cellular viability:

Adaptation Definition Cellular Mechanism Dental / Clinical Examples

Hypertrophy Increase in individual cell size resulting in enlarged organ volume Increased synthesis of structural proteins and organelles; occurs in permanent/non-dividing cells Masseter muscle hypertrophy in severe chronic bruxism/clenching; left ventricular hypertrophy in systemic hypertension.

Hyperplasia Increase in the number of parenchymal cells Growth factor-driven proliferation of mature cells or stem cells; occurs in tissues with mitotic capacity Drug-induced gingival enlargement (nifedipine, phenytoin, cyclosporine); physiological hormonal gingivitis in pregnancy and puberty.

Atrophy Reduction in cell size and metabolic activity, decreasing organ mass Increased protein degradation via ubiquitin-proteasome pathway and increased autophagy Alveolar ridge resorption following extraction (disuse atrophy); senile atrophy of minor salivary glands.

Metaplasia Reversible replacement of one adult, differentiated cell type by another adult cell type Stem cell reprogramming driven by altered transcription factors / cytokines Squamous metaplasia of respiratory columnar epithelium in chronic smokers; salivary duct metaplasia in sialolithiasis; necrotising sialometaplasia .

Note

Clinical Focus — Drug-Induced Gingival Hyperplasia: Three major pharmaceutical classes induce drug-induced gingival enlargement (overgrowth):

Anticonvulsants: Phenytoin (affects ~50% of long-term patients).

Calcium Channel Blockers: Nifedipine (affects up to 20–40% of patients), amlodipine .

Immunosuppressants: Cyclosporine (affects ~30% of solid organ transplant recipients).

All three classes interfere with cellular calcium (Ca²⁺) homeostasis, impairing fibroblast uptake of folic acid and suppressing matrix metalloproteinase production. Fibroblasts synthesize excessive sulfated glycosaminoglycans and collagen, an effect exacerbated by plaque-induced inflammation.

2. Mechanisms of Cell Death: Necrosis versus Apoptosis

When stress exceeds cellular adaptive capacity, irreversible injury leads to cell death:

  • Feature Necrosis Apoptosis
  • Cell Volume Cellular swelling ( oncosis ), organelle swelling Cellular shrinkage , cytoplasmic condensation

Plasma Membrane Disrupted, permeable ; integrity lost early Intact ; blebbing into apoptotic bodies; altered lipid orientation (externalised phosphatidylserine)

Nuclear Morphology Pyknosis ➔ Karyorrhexis ➔ Karyolysis Chromatin condensation; fragmentation into nucleosome-sized units ( DNA laddering )

Inflammatory Response Severe local inflammation (leakage of cellular contents / DAMPs) No inflammation ; prompt macrophage phagocytosis of apoptotic bodies

Mechanism & Energy Passive, unregulated failure; ATP depletion Active, tightly regulated; ATP-dependent ; orchestrated by caspases

Physiological Role Invariably pathological (severe ischemia, toxins, physical trauma) Often physiological (embryogenesis, immune tolerance, elimination of damaged cells); also in DNA damage

Patterns of Tissue Necrosis

Coagulative Necrosis: Default pattern of ischemic tissue necrosis in all solid organs except the brain. Denaturation of structural and enzymatic proteins blocks autolysis, preserving the underlying structural tissue architecture as pale "ghost cells" for several days.

Liquefactive Necrosis: Driven by rapid hydrolytic enzymatic digestion of dead cells, transforming the necrotic parenchyma into a viscous liquid mass (pus). Characterises bacterial abscesses where PMNs release destructive lysosomal hydrolases. Dental pulp necrosis following bacterial ingress through deep dentinal caries represents classic liquefactive necrosis, culminating in an acute periapical abscess.

Caseous Necrosis: Characteristic of tuberculosis ( Mycobacterium tuberculosis ). Grossly presents as friable, cheese-like yellowish debris. Histologically demonstrates an amorphous, structureless, granular eosinophilic core surrounded by a granulomatous collar of epithelioid histiocytes, Langhans giant cells, and lymphocytes.

Gangrenous Necrosis: Clinical term for ischemic coagulative necrosis of a limb or extremity, which can become complicated by secondary bacterial infection leading to superimposed liquefactive necrosis ( wet gangrene ). In malnourished children in developing nations, Cancrum Oris (Noma) presents as a devastating, rapidly spreading gangrenous necrosis of the lips, cheeks, and underlying facial bones.

The Apoptotic Pathways: Intrinsic vs Extrinsic INTRINSIC (MITOCHONDRIAL) PATHWAY EXTRINSIC (DEATH RECEPTOR) PATHWAY

  • ┌─────────────────────────────────┐ ┌──────────────────────────────────┐
  • │ DNA Damage, Hypoxia, Stress │ │ FasL / TNF-α binds Death Receptor│
  • │ Activation of BH3-only proteins │ │ (Fas / CD95 or TNFR1) │
  • │ (BIM, PUMA, NOXA) │ │ │
  • │ BAX / BAK form mitochondrial │ │ Recruitment of Adaptor (FADD) │
  • │ pores (MOMP) │ │ │
  • │ │ │ Cleavage / Activation of │
  • │ Release of CYTOCHROME C │ │ INITIATOR CASPASE-8 │
  • │ Cytochrome c + APAF-1 + dATP │ └────────────────┬─────────────────┘
  • │ ➔ Forms APOPTOSOME │ │
  • │ Activation of INITIATOR │ │ (Cleaves BID to tBID: Crosstalk)
  • │ CASPASE-9 │ │
  • └────────────────┬────────────────┘ │
  • │ │
  • └───────────────────────┬─────────────────────────┘
  • │
  • ▼
  • [EXECUTIONER CASPASES-3 & -7]
  • │
  • ▼
  • Cleave cytoskeletal proteins (actin, lamin)
  • Cleave ICAD ➔ Activates CAD (CAD nuclease)
  • Internucleosomal DNA fragmentation (180–200 bp)
  • │
  • ▼
  • [APOPTOTIC BODY FORMATION]
  • (Externalised Phosphatidylserine)
  • │
  • ▼
  • [Phagocytosis without Inflammation]

Intrinsic (Mitochondrial) Pathway: Triggered by internal cellular stress, growth factor withdrawal, or DNA damage. Governed by the BCL-2 protein family :

Anti-apoptotic: BCL-2, BCL-XL, MCL-1 (preserve outer mitochondrial membrane integrity).

Pro-apoptotic effectors: BAX and BAK .

BH3-only sensors: BIM, BID, PUMA, NOXA (activated by p53 in response to DNA damage).

Upon activation, BAX and BAK oligomerise in the outer mitochondrial membrane, inducing mitochondrial outer membrane permeabilisation (MOMP) . This releases Cytochrome c into the cytosol. Cytochrome c binds APAF-1 (apoptotic protease activating factor-1) in the presence of dATP to form the wheel-shaped apoptosome , which recruits and activates initiator Caspase-9 .

Extrinsic (Death Receptor) Pathway: Triggered by engagement of plasma membrane death receptors belonging to the TNFR family (e.g., Fas / CD95 , TNFR1). Binding of FasL (expressed on cytotoxic T lymphocytes) to Fas causes receptor trimerisation and recruitment of the adaptor protein FADD (Fas-associated death domain), forming the death-inducing signaling complex (DISC) that activates initiator Caspase-8 .

Execution Phase: Both initiator caspases (9 and 8) converge to cleave and activate downstream executioner caspases (Caspase-3, Caspase-6, Caspase-7) . Caspase-3 cleaves the inhibitor of caspase-activated DNase ( ICAD ), releasing CAD to cleave genomic DNA at internucleosomal linker regions, producing the characteristic 180–200 base pair DNA laddering .

Oral Examples of Each Adaptation

General pathology is examined through oral examples, so each adaptive change should be anchored to a lesion you would actually see. Hypertrophy — increased cell size — is seen in the masseter of a bruxist. Hyperplasia — increased cell number — is seen in drug-influenced gingival enlargement with phenytoin, ciclosporin and calcium channel blockers, and in denture-induced fibrous hyperplasia. Atrophy is seen in the epithelium of a patient with iron or B12 deficiency, producing a smooth, depapillated tongue, and in disuse atrophy of alveolar bone after tooth loss. Metaplasia — replacement of one differentiated cell type by another — is seen in the squamous metaplasia of salivary ducts in necrotising sialometaplasia and in smokers' respiratory epithelium. Dysplasia is not an adaptation but a disordered, premalignant change, and the distinction between reversible metaplasia and potentially irreversible dysplasia is a standard examination discrimination.

Why Necrosis and Apoptosis Matter Clinically

The practical difference is inflammation. Necrosis involves membrane failure and the release of cell contents, so it provokes an acute inflammatory response — the mechanism of pulp necrosis leading to periapical periodontitis. Apoptosis is an energy-dependent, regulated dismantling with the cell fragments phagocytosed intact, so it does not provoke inflammation — the mechanism of physiological cell turnover in the oral epithelium and of the deletion of cells with irreparable DNA damage. Loss of apoptotic control through mutation of TP53 is a central step in oral carcinogenesis, which links this section directly to the neoplasia material later in the chapter.

Sections you finish are checked off in the contents.

  • Up Next
  • 10.2 Inflammation, Wound Healing and Repair
  • Continue learning